<?xml version="1.0" encoding="UTF-8"?>
<p>Indonesia reports the highest number of dengue haemorrhagic fever (DHF) cases in the WHO Southeast Asia Region [
 <xref rid="pntd.0008102.ref001" ref-type="bibr">1</xref>], though experts acknowledge that case numbers are largely under-reported and that reporting practices vary substantially by region [
 <xref rid="pntd.0008102.ref004" ref-type="bibr">4</xref>]. The 1997 World Health Organization (WHO) case definitions are used for dengue reporting in Indonesia, where only dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) are notifiable. A cluster-design cross-sectional seroprevalence survey conducted in 2014 estimated an average annual force of infection of 0.140 (95%CI: 0.133–0.147) in urban populations of Indonesia [
 <xref rid="pntd.0008102.ref005" ref-type="bibr">5</xref>]. Jakarta, the capital of Indonesia, is a densely populated megacity with endemic transmission of all 4 dengue serotypes and cyclical epidemics every 3–5 years [
 <xref rid="pntd.0008102.ref006" ref-type="bibr">6</xref>,
 <xref rid="pntd.0008102.ref007" ref-type="bibr">7</xref>]. Current control strategies in Jakarta focus on the removal of mosquito breeding sites by the Mosquito Nest Eradication Program (Pemberantasan Sarang Nyamuk), as well as the periodic use of chemical insecticides for vector management [
 <xref rid="pntd.0008102.ref008" ref-type="bibr">8</xref>].
</p>
